Renato Elias Moreira Júnior
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Renato Elias Moreira Júnior has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Ana Lúcia Brunialti Godard
Laboratório de Genética Animal e Humana, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
5 shared publications - Fernanda Alvarenga Lima Barroso
Department of Genetics, Ecology, and Evolution
2 shared publications Agatha Sondertoft Braga Pedersen
Laboratório de Genética Animal e Humana, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
1 shared publicationAna Maria Caetano Faria
Departmento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
1 shared publication- Ana Maria Caetano Faria
Universidade Federal de Minas Gerais
1 shared publication - Andria dos Santos Freitas
Department of Genetics, Ecology, and Evolution
1 shared publication
Latest Publications
- Open Access
- 21 May 2026
- Published by Taylor & Francis in Gut Microbes Reports
- Vol. 3 (1)
Comparative preventive effects of probiotic and postbiotic preparations of Lacticaseibacillus rhamnosus L156.4 and GG in a 5-FU-induced mucositis model
Intestinal mucositis is a severe chemotherapy side effect, affecting up to 90% of patients. 1 It results from inflammation of the intestinal mucosa and is a common consequence of anticancer treatme...
- 21 May 2026
- Published by Taylor & Francis in Gut Microbes Reports
- Vol. 3 (1)
Open AccessComparative preventive effects of probiotic and postbiotic preparations of Lacticaseibacillus rhamnosus L156.4 and GG in a 5-FU-induced mucositis model
Intestinal mucositis is a severe chemotherapy side effect, affecting up to 90% of patients. 1 It results from inflammation of the intestinal mucosa and is a common consequence of anticancer treatme...
- Open Access
- 30 October 2025
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 49 (11) , 2436-2450
Predicted functional alterations in colonic microbiota metabolism underlie ethanol consumption and preference behavior in mice
Background: Alcohol use disorder (AUD) is a complex condition affecting several body systems. Gut microbiota alterations, intestinal‐barrier disruption, and the consequent translocation of metabolites foster chronic inflammation, lower short‐chain fatty acid (SCFA) output, and depleted beneficial bacteria may contribute to transcriptional, epigenetic, and metabolic changes that influence ethanol preference. Methods: Two experimental phases were used. T1 (8 weeks): mice received either the American Institute of Nutrition standard diet (AING) or a high‐sugar‐butter (HSB) diet. T2 (4 weeks): HSB animals switched to AING (SWITCH), while AING mice maintained the same diet. Each diet arm was split into ethanol (EtOH; free access to 10% ethanol) or H 2 O, generating four groups (AING + H 2 O, AING + EtOH, SWITCH + H 2 O, and SWITCH + EtOH). Sample processing involved colonic‐content collection, 16S rRNA sequencing, microbiome profiling, functional inference, metabolic‐network analysis, and SCFA/amino acid quantification. Results: SWITCH + EtOH mice displayed high ethanol consumption and preference, whereas AING + EtOH mice showed ethanol aversion. Their colonic microbiota differed markedly; amino acid metabolism fell, secondary bile acid synthesis rose, and SCFA production dropped in SWITCH + EtOH animals. Direct measurements confirmed significant reductions in butyrate, acetate, propionate, and selected amino acids. Network analysis revealed enrichment of bacterial metabolism, oxidative stress, and dopamine pathway genes. Conclusions: Diet‐induced dysbiosis, reflected in shifts in microbiota‐derived metabolites, was associated with excessive alcohol intake; the metabolites identified can represent potential therapeutic targets for AUD.
- 30 October 2025
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 49 (11) , 2436-2450
Open AccessPredicted functional alterations in colonic microbiota metabolism underlie ethanol consumption and preference behavior in mice
Background: Alcohol use disorder (AUD) is a complex condition affecting several body systems. Gut microbiota alterations, intestinal‐barrier disruption, and the consequent translocation of metabolites foster chronic inflammation, lower short‐chain fatty acid (SCFA) output, and depleted beneficial bacteria may contribute to transcriptional, epigenetic, and metabolic changes that influence ethanol preference. Methods: Two experimental phases were used. T1 (8 weeks): mice received either the American Institute of Nutrition standard diet (AING) or a high‐sugar‐butter (HSB) diet. T2 (4 weeks): HSB animals switched to AING (SWITCH), while AING mice maintained the same diet. Each diet arm was split into ethanol (EtOH; free access to 10% ethanol) or H 2 O, generating four groups (AING + H 2 O, AING + EtOH, SWITCH + H 2 O, and SWITCH + EtOH). Sample processing involved colonic‐content collection, 16S rRNA sequencing, microbiome profiling, functional inference, metabolic‐network analysis, and SCFA/amino acid quantification. Results: SWITCH + EtOH mice displayed high ethanol consumption and preference, whereas AING + EtOH mice showed ethanol aversion. Their colonic microbiota differed markedly; amino acid metabolism fell, secondary bile acid synthesis rose, and SCFA production dropped in SWITCH + EtOH animals. Direct measurements confirmed significant reductions in butyrate, acetate, propionate, and selected amino acids. Network analysis revealed enrichment of bacterial metabolism, oxidative stress, and dopamine pathway genes. Conclusions: Diet‐induced dysbiosis, reflected in shifts in microbiota‐derived metabolites, was associated with excessive alcohol intake; the metabolites identified can represent potential therapeutic targets for AUD.
- 2 October 2022
- Published by Taylor & Francis in Journal of Neurogenetics
- Vol. 36 (4) , 98-107
Possible association between the lrrk2 gene and anxiety behavior: a systematic literature review
Alterations to the LRRK2 gene have been associated with Parkinson’s disease and alcohol consumption in animals and humans. Furthermore, these disorders are strongly related to anxiety disorders (ADs). Thus, we investigated how the LRRK2 gene might influence anxiety in humans and mice. We elaborated a systematic review based on the PRISMA Statement of studies that investigated levels of anxiety in animal or human models with alterations in the LRRK2 gene. The search was conducted in the PubMed, Scopus, and Web of Science databases, and in reference lists with descriptors related to ADs and the LRRK2. From the 62 articles assessed for eligibility, 16 were included: 11 conducted in humans and seven, in mice. Lrrk2 KO mice and the LRRK2 G2019S, LRRK2 R1441G, and LRRK2 R1441C variants were addressed. Five articles reported an increase in anxiety levels concerning the LRRK2 variants. Decreased anxiety levels were observed in two articles, one focusing on the LRRK2 G2019S and the other, on the Lrrk2 KO mice. Eight other articles reported no differences in anxiety levels in individuals with Lrrk2 alterations compared to their healthy controls. This study discusses a possible influence between the LRRK2 gene and anxiety, adding information to the existing knowledge respecting the influence of genetics on anxiety.
- 2 October 2022
- Published by Taylor & Francis in Journal of Neurogenetics
- Vol. 36 (4) , 98-107
Possible association between the lrrk2 gene and anxiety behavior: a systematic literature review
Alterations to the LRRK2 gene have been associated with Parkinson’s disease and alcohol consumption in animals and humans. Furthermore, these disorders are strongly related to anxiety disorders (ADs). Thus, we investigated how the LRRK2 gene might influence anxiety in humans and mice. We elaborated a systematic review based on the PRISMA Statement of studies that investigated levels of anxiety in animal or human models with alterations in the LRRK2 gene. The search was conducted in the PubMed, Scopus, and Web of Science databases, and in reference lists with descriptors related to ADs and the LRRK2. From the 62 articles assessed for eligibility, 16 were included: 11 conducted in humans and seven, in mice. Lrrk2 KO mice and the LRRK2 G2019S, LRRK2 R1441G, and LRRK2 R1441C variants were addressed. Five articles reported an increase in anxiety levels concerning the LRRK2 variants. Decreased anxiety levels were observed in two articles, one focusing on the LRRK2 G2019S and the other, on the Lrrk2 KO mice. Eight other articles reported no differences in anxiety levels in individuals with Lrrk2 alterations compared to their healthy controls. This study discusses a possible influence between the LRRK2 gene and anxiety, adding information to the existing knowledge respecting the influence of genetics on anxiety.
- 1 June 2021
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 92, 108622
Diet-induced obesity leads to alterations in behavior and gut microbiota composition in mice
- 1 June 2021
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 92, 108622
Diet-induced obesity leads to alterations in behavior and gut microbiota composition in mice